naltrexone and h 89

naltrexone has been researched along with h 89 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Chi, ZQ; Li, M; Liu, JG; Wu, ZQ1
Ghorai, SM; Kumar, S; Rai, U1

Other Studies

2 other study(ies) available for naltrexone and h 89

ArticleYear
Involvement of cAMP/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine.
    Molecular pharmacology, 2006, Volume: 69, Issue:3

    Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Enzyme Inhibitors; Hippocampus; Isoquinolines; Male; Mice; Mice, Inbred Strains; Molecular Mimicry; Morphine; Naltrexone; Okadaic Acid; Pertussis Toxin; Phosphoprotein Phosphatases; Protein Biosynthesis; Protein Kinase Inhibitors; Receptors, Opioid; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Sulfonamides

2006
β-Endorphin inhibits phagocytic activity of lizard splenic phagocytes through μ receptor-coupled adenylate cyclase-protein kinase A signaling pathway.
    General and comparative endocrinology, 2011, May-01, Volume: 171, Issue:3

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; beta-Endorphin; Cyclic AMP-Dependent Protein Kinases; Isoquinolines; Lizards; Naltrexone; Peptides; Phagocytes; Phagocytosis; Receptors, Opioid, mu; Signal Transduction; Spleen; Sulfonamides

2011